$CYDY 8-K SEC Filings

Filed On	Filing
19 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Regulation FD Disclosure CYTODYN INVESTOR UPDATE WEBINAR THE WEBINAR WILL START SOON Participants Jacob Lalezari M.D. Chief Executive Officer of CytoDyn Robert E. Hoffman Chief Financial Officer of CytoDyn Medical Director of GI Oncology, City of Hope Orange Cou...
30 Apr 2026	8-K: Regulation FD Disclosure
24 Mar 2026	8-K: Entry into a Material Definitive Agreement
05 Mar 2026	8-K: Unregistered Sales of Equity Securities
01 Dec 2025	8-K: Other Events
21 Nov 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
03 Nov 2025	8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +1 more
16 May 2025	8-K: Changes in Registrant's Certifying Accountant
06 May 2025	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
22 Nov 2024	8-K: Submission of Matters to a Vote of Security Holders
09 Jul 2024	8-K: Regulation FD Disclosure; Other Events
28 Jun 2024	8-K: Changes in Registrant's Certifying Accountant
03 Jun 2024	8-K: Unregistered Sales of Equity Securities
06 May 2024	8-K: Changes in Registrant's Certifying Accountant
08 Apr 2024	8-K: Termination of a Material Definitive Agreement
28 Mar 2024	8-K: Unregistered Sales of Equity Securities
29 Jan 2024	8-K: Departure/Election of Directors or Officers; Compensation; Regulation FD Disclosure
22 Dec 2023	8-K: Other Events
14 Dec 2023	8-K: Other Events
28 Nov 2023	8-K: Termination of a Material Definitive Agreement

Comments